Flowflex One Step Lateral Flow Test Kit | 5 tests | One Step Test for Sars-CoV-2 Antigen |Covid-19 Self Testing Rapid Test | Not For Travel |

Product Information

Around 1 out of every 5 people who gets COVID-19 becomes seriously ill and develops difficulty breathing. Don’t worry if these reasons don’t apply to you - you'll be able to tell us if you need to be taking regular tests for another reason. They differ from your usual nasopharyngeal lateral flow COVID-19 test as the test only needs to enter the lower nostril, therefore, reducing discomfort without compromising on accuracy. A positive test on the FlowFlex SARS-CoV-2 Rapid Antigen self-test cassette will require for the individual to self-isolate and book a government approved PCR Covid test immediately for confirmation.

Test results are interpreted visually at 15 minutes based on the presence or absence of visually coloured lines. All of a sudden, we had to deal with unprecedented loss and separation, but curbs on our usual freedoms as well. uk accepts no liability for inaccuracies or misstatements about products by manufacturers or other third parties.

Gently squeeze the tube above the sample well on the test cassette and then place 4 drops of the solution. The method of the extraction buffer is used to prepare the test sample by dissolving the virus shell, which also deactivates the virus. You can get your results in just 15 minutes by swabbing your nose, inserting the swab into the pre-filled vial of the test solution, and waiting for the results. Normally the FlowFlex Antigen Test have at least 18 months shelf-life, some batches do extend to 24 months expiry date.

When specimens are processed and added to the test cassette, SARS-CoV-2 antigens, if present in the specimen, will react with the anti-SARS-CoV-2 antibody-coated particles, which have been pre-coated on the test strip. Some mention that it is very good and simple to use, has a handy packet size, and is easy to fit into a bag and take anywhere.

Older people, and those with underlying medical problems like high blood pressure, heart and lung problems, diabetes, or cancer, are at higher risk of developing serious illness. These Flowflex tests are fully Home Use approved and completely non-invasive as they detect the nucleocapsid protein antigen from SARS-CoV-2 via a nasal swab. Lateral flow tests are excellent at detecting COVID-19 in people who have a lot of the virus in their system. Specimens should be tested as quickly as possible after specimen collection and at most within the hour following collection. You can change your choices at any time by visiting Cookie preferences, as described in the Cookie notice.

These Flowflex COVID-19 Rapid Antigen Lateral Flow Test Kits use the latest patented technology in detecting proteins ensuring that it can detect new strains of the COVID-19 virus. They have a good shelf life and I have used again 6 days ago because of Covid symptoms - 2 positive red lines. A box of Rapid Antigen Lateral Flow tests to detect the virus directly from individuals with suspected Covid-19. They are fully approved by UK Government Public Health England, Porton Down Laboratory for Home Use, are very quick and simple to administer, and offer a combined testing accuracy of up to 98. The holder for the tube is in the middle of the box (you punch it out) which was not obvious to me at first.An Antigen lateral flow test kits provide a visual, easy to read result in as little as 15 minutes, which means those who test positive can be instructed to isolate quickly and minimise exposure of COVID-19 in your school, workplace, or community. With a respiratory virus spreading across the globe, many of us may be prone to panic when we feel under the weather. A: The SARS-CoV-2 Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection the nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of the onset of symptoms. Provides an aid in identifying individuals suspected of an active COVID-19 infection by their healthcare provider within the first seven (7) days of the onset of symptoms.